Abstract:Background Public resources of chemical compound are in a rapid growth both in quantity and the types of data-representation. To comprehensively understand the relationship between the intrinsic features of chemical compounds and protein targets is an essential task to evaluate potential protein-binding function for virtual drug screening. In previous studies, correlations were proposed between bioactivity profiles and target networks, especially when chemical structures were similar. With the lack of effective quantitative methods to uncover such correlation, it is demanding and necessary for us to integrate the information from multiple data sources to produce an comprehensive assessment of the similarity between small molecules, as well as quantitatively uncover the relationship between compounds and their targets by such integrated schema. Results In this study a multi-view based clustering algorithm was introduced to quantitatively integrate compound similarity from both bioactivity profiles and structural fingerprints. Firstly, a hierarchy clustering was performed with the fused similarity on 37 compounds curated from PubChem. Compared to clustering in a single view, the overall common target number within fused classes has been improved by using the integrated similarity, which indicated that the present multi-view based clustering is more efficient by successfully identifying clusters with its members sharing more number of common targets. Analysis in certain classes reveals that mutual complement of the two views for compound description helps to discover missing similar compound when only single view was applied. Then, a large-scale drug virtual screen was performed on 1267 compounds curated from Connectivity Map (CMap) dataset based on the fused similarity, which obtained a better ranking result compared to that of single-view. These comprehensive tests indicated that by combining different data representations; an improved assessment of target-specific compound similarity can be achieved. Conclusions Our study presented an efficient, extendable and quantitative computational model for integration of different compound representations, and expected to provide new clues to improve the virtual drug screening from various pharmacological properties. Scripts, supplementary materials and data used in this study are publicly available at http://lifecenter.sgst.cn/fusion/ .

2D depiction of biological interactions and its applications in drug design

2D Molecular Graphics: a Flattened World of Chemistry and Biology.

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Computer Modeling for Interaction of Ligands and Receptors and Their Applications in Drug Design

2D Depiction of Nonbonding Interactions for Protein Complexes.

Molecular docking as a popular tool in drug design, an in silico travel

Molecular dynamics simulations and novel drug discovery

Chemical structure representations and applications in computational toxicity

VNP: Interactive Visual Network Pharmacology of Diseases, Targets, and Drugs

Molecular modeling: A powerful tool for drug design and molecular docking

Towards Structure-Based Protein Drug Design

Quantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysis

Exploration and Experience on Computer-aided Drug Design Experiment

Computational Methods for Structure-Based Drug Design Through System Biology.

2D materials-based nanomedicine: From discovery to applications

Enhanced optical imaging and fluorescent labeling for visualizing drug molecules within living organisms

Volumetric Visualization And Analysis Of Molecular Interaction Field

Recent Trends in Drug Design and Discovery

Structure-based drug design: From nucleic acid to membrane protein targets

Two-dimensional nanomaterials induced nano-bio interfacial effects and biomedical applications in cancer treatment